CBP/p300-IN-22
Product Specifications
Target
NF-κB, Epigenetic Reader Domain, Histone Acetyltransferase
Related Pathways
Chromatin/Epigenetic, NF-κB
Bioactivity
CBP/p300-IN-22 is a selective inhibitor of the CBP/EP300 bromodomain, with an IC50 of 4 nM. It exhibits high selectivity for BRD4 (1) and reduces cytokine expression induced by TNF-α as well as subsequent immune cell recruitment by inhibiting NF-κB signaling, demonstrating anticancer properties. This compound is applicable for research into rheumatoid arthritis (RA) and other TNF-α-mediated inflammatory diseases.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402308-100 1x 100 µL
HSP27 (Heat Shock Protein 27) (rHSPB1/774), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940106-500 1x 500 µL
Human Nuclear Antigen (NM106), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details